Publicaciones en colaboración con investigadoras/es de Memorial Sloan Kettering Cancer Center (35)

2023

  1. Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL

    Blood, Vol. 141, Núm. 18, pp. 2194-2205

2022

  1. Immobilization of Biantennary N-Glycans Leads to Branch Specific Epitope Recognition by LSECtin

    ACS Central Science, Vol. 8, Núm. 10, pp. 1415-1423

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Author Correction: Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate (Nature Genetics, (2009), 41, 5, (619-624), 10.1038/ng.370)

    Nature Genetics

  2. Epigenetic reprogramming sensitizes immunologically silent EBV1 lymphomas to virus-directed immunotherapy

    Blood, Vol. 135, Núm. 21, pp. 1870-1881

2019

  1. Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL

    Nature Communications, Vol. 10, Núm. 1

  2. Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia

    Nature, Vol. 569, Núm. 7757, pp. 576-580

  3. Somatic mutations and cell identity linked by Genotyping of Transcriptomes

    Nature, Vol. 571, Núm. 7765, pp. 355-360

2017

  1. Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers

    Cancer Discovery, Vol. 7, Núm. 8, pp. 868-883

  2. Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by Bora

    Oncogene, Vol. 36, Núm. 13, pp. 1840-1848

  3. MTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer

    Nature, Vol. 547, Núm. 7661, pp. 109-113

2016

  1. Optimized Protocol to Analyze Changes in the Lipidome of Xenografts after Treatment with 2-Hydroxyoleic Acid

    Analytical Chemistry, Vol. 88, Núm. 1, pp. 1022-1029

  2. Stratification and therapeutic potential of PML in metastatic breast cancer

    Nature Communications, Vol. 7

  3. The metabolic co-regulator PGC1α suppresses prostate cancer metastasis

    Nature Cell Biology, Vol. 18, Núm. 6, pp. 645-656

2015

  1. Methodological aspects of the molecular and histological study of prostate cancer: Focus on PTEN

    Methods, Vol. 77, pp. 25-30

  2. Regulation of ceramide generation during macrophage apoptosis by ASMase and de novo synthesis

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1851, Núm. 11, pp. 1482-1489

2014

  1. A unified nomenclature and amino acid numbering for human PTEN

    Science Signaling, Vol. 7, Núm. 332

  2. Analysis of the lipidome of xenografts using MALDI-IMS and UHPLC-ESI-QTOF

    Journal of the American Society for Mass Spectrometry, Vol. 25, Núm. 7, pp. 1237-1246

  3. RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation

    EMBO Molecular Medicine, Vol. 6, Núm. 7, pp. 865-881

2013

  1. New interfacial microtubule inhibitors of marine origin, PM050489/PM060184, with potent antitumor activity and a distinct mechanism

    ACS Chemical Biology, Vol. 8, Núm. 9, pp. 2084-2094